Literature DB >> 21402838

Insertion sequence ISAba11 is involved in colistin resistance and loss of lipopolysaccharide in Acinetobacter baumannii.

Jennifer H Moffatt1, Marina Harper, Ben Adler, Roger L Nation, Jian Li, John D Boyce.   

Abstract

Infections caused by Acinetobacter baumannii are of increasing concern, largely due to the multidrug resistance of many strains. Here we show that insertion sequence ISAba11 movement can result in inactivation of the A. baumannii lipid A biosynthesis genes lpxA and lpxC, resulting in the complete loss of lipopolysaccharide production and high-level colistin resistance.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21402838      PMCID： PMC3101452          DOI： 10.1128/AAC.01732-10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  11 in total

1.  A novel insertion sequence, ISAba10, inserted into ISAba1 adjacent to the bla(OXA-23) gene and disrupting the outer membrane protein gene carO in Acinetobacter baumannii.

Authors:  Yangsoon Lee; Chang-Ki Kim; Hyukmin Lee; Seok Hoon Jeong; Dongeun Yong; Kyungwon Lee
Journal:  Antimicrob Agents Chemother       Date:  2010-10-11       Impact factor: 5.191

2.  Prevalence and spread of integron-IS26 in imipenem-resistant Acinetobacter baumannii clinical isolates in South Korea.

Authors:  Ok Yeon Jeoung; Sook-Jin Jang; Xue Min Li; Geon Park; Dong Eun Yong; Jung Oak Kang; Sun Hoe Koo; Won Yong Kim; Eui Chong Kim; Yeon Joon Park; Won Keun Song; Jong Hee Shin; Ji Young Ahn; Young Uh; Kyung Won Lee; Sung Hee Lee; Wee Gyo Lee; Hye Soo Lee; Tae Yeal Choi; Ji Hyun Cho; Seok Hoon Jeong; Seong Geon Hong; Jongwook Lee; Dong Min Kim; Chulhun L Chang; Sung Heui Shin; Dae Soo Moon; Young Jin Park
Journal:  Int J Antimicrob Agents       Date:  2009-09-06       Impact factor: 5.283

Review 3.  DDE transposases: Structural similarity and diversity.

Authors:  Irina V Nesmelova; Perry B Hackett
Journal:  Adv Drug Deliv Rev       Date:  2010-07-06       Impact factor: 15.470

4.  Evolution of AbaR-type genomic resistance islands in multiply antibiotic-resistant Acinetobacter baumannii.

Authors:  Virginia Post; Peter A White; Ruth M Hall
Journal:  J Antimicrob Chemother       Date:  2010-04-07       Impact factor: 5.790

5.  Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production.

Authors:  Jennifer H Moffatt; Marina Harper; Paul Harrison; John D F Hale; Evgeny Vinogradov; Torsten Seemann; Rebekah Henry; Bethany Crane; Frank St Michael; Andrew D Cox; Ben Adler; Roger L Nation; Jian Li; John D Boyce
Journal:  Antimicrob Agents Chemother       Date:  2010-09-20       Impact factor: 5.191

6.  Cephalosporinase over-expression resulting from insertion of ISAba1 in Acinetobacter baumannii.

Authors:  C Héritier; L Poirel; P Nordmann
Journal:  Clin Microbiol Infect       Date:  2006-02       Impact factor: 8.067

Review 7.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

8.  AmpC cephalosporinase hyperproduction in Acinetobacter baumannii clinical strains.

Authors:  Stéphane Corvec; Nathalie Caroff; Eric Espaze; Cécile Giraudeau; Henri Drugeon; Alain Reynaud
Journal:  J Antimicrob Chemother       Date:  2003-09-01       Impact factor: 5.790

9.  New insights into Acinetobacter baumannii pathogenesis revealed by high-density pyrosequencing and transposon mutagenesis.

Authors:  Michael G Smith; Tara A Gianoulis; Stefan Pukatzki; John J Mekalanos; L Nicholas Ornston; Mark Gerstein; Michael Snyder
Journal:  Genes Dev       Date:  2007-03-01       Impact factor: 11.361

10.  IS4 family goes genomic.

Authors:  Daniel De Palmenaer; Patricia Siguier; Jacques Mahillon
Journal:  BMC Evol Biol       Date:  2008-01-23       Impact factor: 3.260
View more
  72 in total

1.  Colistin resistance in a clinical Acinetobacter baumannii strain appearing after colistin treatment: effect on virulence and bacterial fitness.

Authors:  Rafael López-Rojas; Michael J McConnell; Manuel Enrique Jiménez-Mejías; Juan Domínguez-Herrera; Felipe Fernández-Cuenca; Jerónimo Pachón
Journal:  Antimicrob Agents Chemother       Date:  2013-07-08       Impact factor: 5.191

2.  Inhibition of LpxC Increases Antibiotic Susceptibility in Acinetobacter baumannii.

Authors:  Meritxell García-Quintanilla; José M Caro-Vega; Marina R Pulido; Patricia Moreno-Martínez; Jerónimo Pachón; Michael J McConnell
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

3.  Activity of host antimicrobials against multidrug-resistant Acinetobacter baumannii acquiring colistin resistance through loss of lipopolysaccharide.

Authors:  Meritxell García-Quintanilla; Marina R Pulido; Patricia Moreno-Martínez; Reyes Martín-Peña; Rafael López-Rojas; Jerónimo Pachón; Michael J McConnell
Journal:  Antimicrob Agents Chemother       Date:  2014-02-24       Impact factor: 5.191

Review 4.  Antimicrobial heteroresistance: an emerging field in need of clarity.

Authors:  Omar M El-Halfawy; Miguel A Valvano
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

Review 5.  Antimicrobial Susceptibility Testing for Polymyxins: Challenges, Issues, and Recommendations.

Authors:  Fereshteh Ezadi; Abdollah Ardebili; Reza Mirnejad
Journal:  J Clin Microbiol       Date:  2019-03-28       Impact factor: 5.948

Review 6.  Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes.

Authors:  Laurent Poirel; Aurélie Jayol; Patrice Nordmann
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

7.  Real-time sequencing to decipher the molecular mechanism of resistance of a clinical pan-drug-resistant Acinetobacter baumannii isolate from Marseille, France.

Authors:  Jean-Marc Rolain; Seydina M Diene; Marie Kempf; Gregory Gimenez; Catherine Robert; Didier Raoult
Journal:  Antimicrob Agents Chemother       Date:  2012-10-15       Impact factor: 5.191

Review 8.  Rescuing the Last-Line Polymyxins: Achievements and Challenges.

Authors:  Sue C Nang; Mohammad A K Azad; Tony Velkov; Qi Tony Zhou; Jian Li
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

9.  Lipopolysaccharide-deficient Acinetobacter baumannii shows altered signaling through host Toll-like receptors and increased susceptibility to the host antimicrobial peptide LL-37.

Authors:  Jennifer H Moffatt; Marina Harper; Ashley Mansell; Bethany Crane; Timothy C Fitzsimons; Roger L Nation; Jian Li; Ben Adler; John D Boyce
Journal:  Infect Immun       Date:  2012-12-17       Impact factor: 3.441

10.  Pan-transcriptomic analysis identified common differentially expressed genes of Acinetobacter baumannii in response to polymyxin treatments.

Authors:  Mengyao Li; Su Mon Aye; Maizbha Uddin Ahmed; Mei-Ling Han; Chen Li; Jiangning Song; John D Boyce; David R Powell; Mohammad A K Azad; Tony Velkov; Yan Zhu; Jian Li
Journal:  Mol Omics       Date:  2020-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.